PRQR stock - ProQR Therapeutics N.V.

Industry: Biotechnology Sector: Healthcare Exchange: NASDAQ

Fri 16'th Nov 2018

PERIOD 2018-08-17 - 2018-11-16
CHANGE 4.83%
PRICE $20.42




Request Prediction

ProQR Therapeutics N.V. Stock Analysis

Technical stock analysis for Fri 16'th Nov 2018

Buy candidate since 2018-11-15 Gain 4.83%
Shorts n/a
Cash n/a
Loans n/a
Beta 0.54
ROA -42.72

ProQR Therapeutics N.V. gained 4.83% in the last trading day, rising from $19.48 to $20.42 , and has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. The price has fallen in 6 of the last 10 days and is down by -8.84% for this period. Volume fell in the last day by -338 733 shares, and in total, 536 568 shares bought and sold for approximately $10.96 million. You should take into consideration that a falling volume on higher prices causes divergence and may be an early warning about possible changes for the next couple of days.


ProQR Therapeutics N.V. lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 55.8% during the next 3 months and, with 90% probability hold a price between $27.16 and $46.01 at the end of this period.

Click here for today's Top 5 Trending Companies


Only positive signals in the chart today. ProQR Therapeutics N.V. holds buy signals from both short- and long-term moving averages. In addition, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down there will be some support from the lines at $19.20 and $18.90. A break down below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Wednesday November 14, 2018, which indicates further gains until a new top pivot has been found. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and may be an early warning. The stock should be watched closely.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

RSI14 is 62 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

On the downside, the stock finds support just below today's level from accumulated volume at $18.65 and $17.55.

There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, ProQR Therapeutics N.V. finds support just below today's level at $18.65. If this is broken, then the next support from accumulated volume will be at $17.55 and $15.80.

Support: $18.65 Price: $20.42 Resistance: $20.80


This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $1.59 between high and low, or 8.23%. For the last week, the stock has had a daily average volatility of 8.27%.

Our recommended stoploss: $19.55 (-4.28%) (This stock has high daily movements and this gives high risk. There is a buy signal from pivot bottom found 2 days ago.)

Overall risk:

Very Low Low Medium High Very High


ProQR Therapeutics N.V. holds several positive signals and is within a strong rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months.

PRQR $20.42 $0.94(4.83%)
PRQR is up $0.94 today, but where's it headed in 2019?
Zacks Investment Research is releasing its prediction for PRQR based on the 1-3 month system that more than doubles the S&P 500.

Click here – the PRQR analysis is free »

Last donation

Do you find our website useful too?
Help us improve by making a small donation or
Get PRO features

Proudly made at

in partnership with